Evidence map›Paper›PMID 42529415›Full record

ArticleFrontiers in pediatrics2026

Marco Manfredi, Luca Braglia, Alessio Canovi, Giuseppe Pagliaro

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marco ManfrediPediatric Unit, Maternal and Child Department, Azienda USL-IRCCS di Reggio Emilia, Sant'Anna Hospital, Castelnovo ne' Monti, Reggio Emilia, Italy.
Luca BragliaClinical Trials Center, Infrastruttura Ricerca e Statistica, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Alessio CanoviPediatric Gastroenterology Outpatient Clinic, Pediatric Unit, Maternal and Child Department, Azienda USL-IRCCS di Reggio Emilia, ASMN Hospital, Reggio Emilia, Italy.
Giuseppe PagliaroPediatric Gastroenterology Outpatient Clinic, Pediatric Unit, Maternal and Child Department, Azienda USL-IRCCS di Reggio Emilia, ASMN Hospital, Reggio Emilia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: No specific symptomatology or typical endoscopic features exist for children infected with Methods: We retrospectively analyzed all children infected with Results: Clinical and endoscopic features did not differ significantly between the groups, confirming that one cannot diagnose Discussion: We confirm that infected and non-infected children present with similar clinical and macroscopic features in gastroscopy and resistance to amoxicillin and tetracycline remains very low. While the small sample sizes limit sweeping conclusions, tailored therapy demonstrated maximum efficacy. Empiric regimens should be avoided if resistance testing is available. Alternatively, clinicians should select antibiotics with the lowest probability of resistance, such as amoxicillin, tetracycline, or metronidazole.

Indexed as

antimicrobial susceptibilitychildrenclinical symptomsendoscopic featuresHelicobacter pylori

Identifiers

PMID42529415
PMCPMC13417099

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.